| (210) | Number of the EPO application | 23160271 |
| (220) | Filing date of the EPO application | 2019.11.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 40/2024, 2024.10.02 |
| (110) | EPO patent number | 4233850 |
| (11) | Number of the document | MD 4233850 T2 |
| (21) | Number of the application | e 2023 1131 |
| (71) | Name(s) of applicant(s), code of the country | CHEMOCENTRYX, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | LELETI Manmohan Reddy, US;
POWERS Jay P, US; |
| (73) | Name(s) of owner(s), code of the country | CHEMOCENTRYX, INC., US; |
| (54) | Title of the invention | Capsule formulations |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/48 (2006.01.01); A61K 31/451 (2006.01.01); A61K 47/10 (2017.01.01); A61K 47/14 (2017.01.01); A61K 47/40 (2006.01.01); A61K 47/44 (2017.01.01); A61P 29/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2023.12.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2025.02.28 |
| (30) | Priority | 201862773848 P, 2018.11.30, US |
| (74) | Patent attorney | (Procedură) JENICICOVSCAIA Galina, Str. Miron Costin nr. 15/2, of. 19-20, MD-2045, Chişinău, Republica Moldova |